MedTrace Logo

Prevalence of Helicobacter Pylori Infection and Gastric Cancer in the West Indies

NCT04949737 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 112

Last updated 2026-03-31

No results posted yet for this study

Summary

Estimating the prevalence of Helicobacter Pylori infection in newly diagnosed stomach cancers in the West-Indies will help to understand the epidemiology of this cancer, which is over-incident in the West Indies compared to France. In addition, the constitution of a biobank (tumor tissues, healthy tissues and serum) will allow to set up in a second time etiological studies to identify other risk factors in particular in connection with the exposure to environmental pollutants to adapt the prevention measures.

Conditions

  • Stomach Neoplasms
  • Gastric Neoplasms
  • Helicobacter Pylori

Interventions

BIOLOGICAL

Helicobacter Pylori detection

Biopsies will be sent to the referral anatomopathology laboratory. The search for Helicobacter pylori will be performed by immunohistochemistry. An additional blood sample for serological testing will be taken during the initial workup. Additional data will be collected through a questionnaire.

Sponsors & Collaborators

  • University Hospital Center of Martinique

    lead OTHER

Principal Investigators

  • Clarisse JOACHIM-CONTARET · CHU Martinique

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-10-09
Primary Completion
2028-04-30
Completion
2028-12-31

Countries

  • Martinique

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04949737 on ClinicalTrials.gov